Outcome of Chronic Subdural Hematoma Intervention in Patients on Long-Term Antiplatelet Therapy-A Propensity Score Matched Analysis.

Mira SalihMichael YoungAlfonso GarciaMartina StipplerEfstathios PapavassiliouRon L AltermanAjith J ThomasPhilipp TausskyJustin MooreChristopher S Ogilvy

Published in: Neurosurgery (2023)

Preintervention antiplatelet medications before cSDH treatment do not affect length of hospitalization, periprocedural complications, or reintervention. Resumption of antiplatelet medication after cSDH procedures does not increase the rebleeding risk or reintervention rate.

Keyphrases

antiplatelet therapy
percutaneous coronary intervention
end stage renal disease
acute coronary syndrome
randomized controlled trial
newly diagnosed
chronic kidney disease
ejection fraction
healthcare
prognostic factors
peritoneal dialysis
coronary artery disease
emergency department
patient reported